Glesatinib hydrochloride
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-19642A-50 mg |
| CAS # | 1123838-51-6 |
| Pricing | 50 mg, USD $1500.0 |
| Synonyms | MGCD265 hydrochloride |
| MWt | 656.17 |
| Formula | C₃₁H₂₈ClF₂N₅O₃S₂ |
| Biological Activity | Glesatinib hydrochloride (MGCD265 hydrochloride) is an orally active, potent MET/SMO dual inhibitor. Glesatinib hydrochloride, a tyrosine kinase inhibitor, antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC)[1][2]. |
| Purity | ≥98.0% |